Johnson & Johnson announced a lead vaccine candidate for COVID-19
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
Bellerophon Therapeutics announced first patient treated with INOpulse inhaled nitric oxide therapy for COVID-19
On Mar. 30, 2020, Bellerophon Therapeutics announced that expanded access treatment with the INOpulse inhaled nitric oxide system…
Study documents widespread contamination of environment near patients with COVID-19
On Mar. 29, 2020, a study by UNMC/Nebraska Medicine/NSRI researchers provides new evidence of SARS-CoV-2 environmental contamination in…
FDA issued EUA to allow hydroxychloroquine sulfate and chloroquine phosphate products from Strategic National Stockpile to be distributed
On Mar. 28, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to…
Military scientists, engineers develop ventilator prototype
On Mar. 27, 2020, scientists and engineers at Naval Surface Warfare Center Panama City Division announced development of…
Abbott launched molecular point-of-care test to detect novel Coronavirus in as Little as five minutes
On Mar. 27, 2020, Abbott announced the FDA has issued Emergency Use Authorization (EUA) for the fastest available…
Medtronic launched new solutions to help monitor patients for COVID-19
On Mar. 27, 2020, Medtronic announced its Medtronic Care Management Services (MCMS) business had launched two new solutions…
Oxford University COVID-19 vaccine programme opened for clinical trial recruitment
On Mar. 27, 2020, University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19…
Abbott launched molecular point-of-care test to detect novel Coronavirus in as little as five minutes
On Mar. 27, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the fastest…
COVID-19 will likely lead to US drug shortages
On Mar. 27, 2020, researchers at the University of Minnesota reported that the COVID-19 pandemic stands a good…
Biotechnology | COVID-19 | Diagnostics | FDA
CIRM approved $5 Million in emergency funding for COVID-19 research
On Mar. 27, 2020, in response to the crisis caused by the COVID-19 virus in California and around…
Biotechnology | COVID-19 | Diagnostics | FDA | Life Science History | Life Science News | Therapeutics
Humanigen submitted phase III protocol synopsis to FDA for lenzilumab for Coronavirus treatment
On Mar. 27, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to U.S. Food…
Emory University new site in NIH-sponsored coronavirus vaccine study
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
Syneos Health launched Ventilator Initiative to raise awareness of bridging option to address ventilator shortage
On Mar. 27, 2020, Syneos Health announced the launch of a Ventilator Initiative. This multi-disciplinary initiative is designed…
COVID-19 | Diagnostics | FDA | Medical Device
Luminex receives FDA Emergency Use Authorization for NxTAG CoV Extended Panel to detect SARS-CoV-2 Virus
On Mar. 27, 2020, Luminex announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization…
Rice University and Metric Technologies develop $300 ventilator freely available
On Mar. 27, 2020, Rice University and Canadian global health design firm Metric Technologies announced they have developed…
Thermo Fisher Scientific received CE Mark for its diagnostic test todDetect COVID-19
On Mar. 26, 2020, Thermo Fisher Scientific announced it had received the CE mark in the European Union…
Novartis and life sciences companies commited to fight against COVID-19 with Bill & Melinda Gates Foundation
On Mar. 26, 2020, Novartis and a consortium of life sciences companies announced a collaboration to accelerate the…
COVID-19 first target of new AI research consortium
On Mar. 26, 2020, the University of California, Berkeley, and University of Illinois at Urbana-Champaign were selected a…
WHO Director-General calls on G20 to fight, unite, and ignite against COVID-19
On Mar. 26, 2020, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), addressed Heads of…
FDA supports transparency and collaboration in drug approval process as clinical data summary pilot concluded
On Mar. 26, 2020, the FDA reported that it had become increasingly clear that the FDA needed to…
U.S. hospitals could be overwhelmed in the second week of April and US deaths could total 81,000 by July
On Mar. 26, 2020, in a forecast based on recent data analyses, Institute for Health Metrics (IHME) researchers…
Cerus formed group to research optimal production of COVID-19 convalescent plasma
On Mar. 26, 2020, Cerus announced it had formed a collaborative research group with the aim of optimizing…
Biotechnology | COVID-19 | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Amyris launched hand sanitizer and receives initial positive result for vaccine adjuvant
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
Dynavax and CEPI announced collaboration to support effort to develop vaccine for COVID-19
On Mar. 26, 2020, Dynavax and the Coalition for Epidemic Preparedness Innovations (CEPI) announced a collaboration supporting the…
Biotechnology | COVID-19 | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
UC Health launched clinical trials to assess antiviral drug for COVID-19
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
Broad Institute’s CLIA-certified testing center began processing COVID-19 patient samples
On Mar. 26, 2020, working in partnership with the Commonwealth of Massachusetts, Massachusetts State Public Health Laboratory, and…
Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of Texas
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
Henry Schein announced availability of COVID-19 point-of-care antibody rapid test
On Mar. 26, 2020, Henry Schein announced the availability of an antibody rapid blood test, known as Standard…
iBio announced advancement of COVID-19 vaccine program
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…